No. |
Variant name |
Chromosome position |
Chromatin state |
Related regulatory elements |
Target genes |
Extended variants |
Associated traits |
1 |
rs2298260 |
chr9:21029330-21029331 |
Weak transcription Enhancers Genic enhancers Strong transcription Flanking Active TSS
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
mRNA abundance
|
2 |
rs376919713 |
chr9:21029358-21029359 |
Weak transcription Enhancers Genic enhancers Strong transcription Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
3 |
rs79392110 |
chr9:21029382-21029383 |
Weak transcription Enhancers Genic enhancers Strong transcription Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
4 |
rs182838456 |
chr9:21029383-21029384 |
Weak transcription Enhancers Genic enhancers Strong transcription Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
5 |
rs528813460 |
chr9:21029386-21029387 |
Weak transcription Enhancers Genic enhancers Strong transcription Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
6 |
rs201174106 |
chr9:21029400-21029401 |
Weak transcription Enhancers Genic enhancers Strong transcription Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
7 |
rs368372470 |
chr9:21029404-21029405 |
Weak transcription Enhancers Genic enhancers Strong transcription Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
8 |
rs370959089 |
chr9:21029426-21029427 |
Weak transcription Enhancers Genic enhancers Strong transcription Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
9 |
rs139651010 |
chr9:21029493-21029494 |
Weak transcription Enhancers Genic enhancers Strong transcription Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
10 |
rs561435829 |
chr9:21029547-21029548 |
Weak transcription Enhancers Genic enhancers Strong transcription Flanking Active TSS
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
11 |
rs533521607 |
chr9:21029561-21029562 |
Weak transcription Enhancers Genic enhancers Strong transcription Flanking Active TSS
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
12 |
rs142919654 |
chr9:21029625-21029626 |
Weak transcription Enhancers Genic enhancers Flanking Active TSS
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
13 |
rs372725306 |
chr9:21029634-21029635 |
Weak transcription Enhancers Genic enhancers Flanking Active TSS
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
14 |
rs568915911 |
chr9:21029637-21029638 |
Weak transcription Enhancers Genic enhancers Flanking Active TSS
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
15 |
rs151093016 |
chr9:21029687-21029688 |
Weak transcription Enhancers Genic enhancers Flanking Active TSS
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
16 |
rs7037601 |
chr9:21029706-21029707 |
Weak transcription Enhancers Genic enhancers Flanking Active TSS
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
17 |
rs77734407 |
chr9:21029718-21029719 |
Weak transcription Enhancers Genic enhancers Flanking Active TSS
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
18 |
rs12378299 |
chr9:21029802-21029803 |
Weak transcription Enhancers Flanking Active TSS Genic enhancers
|
TF binding region
|
1 gene(s)
|
LD-proxies of rSNPOverlapped rCNV
|
mRNA abundance
|
19 |
rs117999932 |
chr9:21029811-21029812 |
Weak transcription Enhancers Flanking Active TSS Genic enhancers
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
20 |
rs547636188 |
chr9:21029833-21029834 |
Weak transcription Enhancers Flanking Active TSS Genic enhancers
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
21 |
rs139940663 |
chr9:21029840-21029841 |
Weak transcription Enhancers Flanking Active TSS Genic enhancers
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
22 |
rs570069863 |
chr9:21029861-21029862 |
Weak transcription Enhancers Flanking Active TSS Genic enhancers
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
23 |
rs6475499 |
chr9:21029863-21029864 |
Weak transcription Enhancers Flanking Active TSS Genic enhancers
|
TF binding region
|
1 gene(s)
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
24 |
rs556119453 |
chr9:21029866-21029867 |
Weak transcription Enhancers Flanking Active TSS Genic enhancers
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
25 |
rs12378278 |
chr9:21029876-21029877 |
Weak transcription Enhancers Flanking Active TSS Genic enhancers
|
TF binding region
|
1 gene(s)
|
LD-proxies of rSNPOverlapped rCNV
|
mRNA abundance
|
26 |
rs112086078 |
chr9:21029902-21029903 |
Weak transcription Enhancers Flanking Active TSS Genic enhancers
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
27 |
rs546648557 |
chr9:21029942-21029943 |
Weak transcription Enhancers Flanking Active TSS Genic enhancers
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
28 |
rs372204383 |
chr9:21029955-21029956 |
Weak transcription Enhancers Flanking Active TSS Genic enhancers
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
29 |
rs191644655 |
chr9:21029962-21029963 |
Weak transcription Enhancers Flanking Active TSS Genic enhancers
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
30 |
rs541085266 |
chr9:21029973-21029974 |
Weak transcription Enhancers Flanking Active TSS Genic enhancers
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
31 |
rs77331745 |
chr9:21030092-21030093 |
Weak transcription Enhancers Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
32 |
rs74958760 |
chr9:21030093-21030094 |
Weak transcription Enhancers Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
33 |
rs543988253 |
chr9:21030156-21030157 |
Weak transcription Enhancers Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
34 |
rs563778108 |
chr9:21030164-21030165 |
Weak transcription Enhancers Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
35 |
rs7875765 |
chr9:21030165-21030166 |
Weak transcription Enhancers Flanking Active TSS
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
mRNA abundance
|
36 |
rs183738793 |
chr9:21030181-21030182 |
Weak transcription Enhancers Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
37 |
rs564654173 |
chr9:21030184-21030185 |
Weak transcription Enhancers Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
38 |
rs527265300 |
chr9:21030204-21030205 |
Weak transcription Enhancers Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
39 |
rs535402187 |
chr9:21030210-21030211 |
Weak transcription Enhancers Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
40 |
rs547106809 |
chr9:21030219-21030220 |
Weak transcription Enhancers Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
41 |
rs368743266 |
chr9:21030268-21030269 |
Weak transcription Enhancers Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
42 |
rs535809011 |
chr9:21030269-21030270 |
Weak transcription Enhancers Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
43 |
rs76591760 |
chr9:21030283-21030284 |
Weak transcription Enhancers Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
44 |
rs397800832 |
chr9:21030286-21030287 |
Weak transcription Enhancers Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
45 |
rs557194959 |
chr9:21030290-21030291 |
Weak transcription Enhancers Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
46 |
rs567536720 |
chr9:21030301-21030302 |
Weak transcription Enhancers Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
47 |
rs568962459 |
chr9:21030302-21030303 |
Weak transcription Enhancers Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
48 |
rs188269673 |
chr9:21030339-21030340 |
Weak transcription Enhancers Flanking Active TSS
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
49 |
rs147553499 |
chr9:21030368-21030369 |
Weak transcription Enhancers Flanking Active TSS
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
50 |
rs141946566 |
chr9:21030386-21030387 |
Weak transcription Enhancers Flanking Active TSS
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|